Skip to main content

Dartisla ODT Dosage

Generic name: GLYCOPYRROLATE 1.7mg
Dosage form: orally disintegrating tablets tablets
Drug class: Anticholinergics / antispasmodics

Medically reviewed by Last updated on Dec 9, 2021.

Important Dosing Information

  • Patients receiving the 2 mg dosage strength of another oral tablet dosage form of glycopyrrolate may be switched to the 1.7 mg dosage strength of DARTISLA ODT [see Dosage Forms and Strengths (3) and Clinical Pharmacology (12.3)].

  • DARTISLA ODT is not recommended for patients in whom a lower dosage strength of another oral glycopyrrolate product (e.g., tablet strength of 1 mg) is appropriate for initial or maintenance treatment because the dosage strength of DARTISLA ODT may exceed the recommended initial and maintenance dosage of other oral glycopyrrolate products.

Recommended Dosage

  • The recommended dosage of DARTISLA ODT is 1.7 mg given two or three times daily administered on top of the tongue. Allow the tablet to disintegrate and swallow without water [see Clinical Pharmacology (12.3)].
  • The maximum recommended daily dosage of DARTISLA ODT is 6.8 mg.
  • Administer DARTISLA ODT at least one hour before or two hours after food [see Clinical Pharmacology (12.3)].
  • Use the lowest effective dosage of glycopyrrolate to control symptoms. Switch patients who can be titrated to a lower dose of oral glycopyrrolate to another oral tablet dosage form of glycopyrrolate.

Administration Instructions

  • Use dry hands when opening the blister card and do not open the blister until ready to administer.
  • Open the package and peel back the foil on the blister to expose the tablet and gently remove from the blister. Do not push the tablet through the foil.
  • Do not break or cut the tablet.
  • Immediately place the tablet on the tongue, allow it to disintegrate, and swallow without water.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.